Department of Personality, Evaluation and Psychological Treatment, University of Valencia, Avenida Blasco Ibáñez, 21, 46010, Valencia, Spain.
CIBER of Physiopathology of Obesity and Nutrition (CIBEROBN), ISCIII CB06/03/0052, Instituto Salud Carlos III, 28029, Madrid, Spain.
BMC Psychiatry. 2022 Mar 5;22(1):164. doi: 10.1186/s12888-022-03800-x.
CUIDA-TE is an APP that offers transdiagnostic cognitive behavioral therapy focused on enhancing emotion regulation. As a novelty, it incorporates ecological momentary interventions (EMI), which can provide psychological support in real time, when suffering arises. The main goal of the study is to evaluate the efficacy of CUIDA-TE to improve emotion regulation in healthcare workers, a population that has been particularly emotionally impacted by the COVID-19 pandemic.
In this three-arm, randomized controlled trial (RCT) the study sample will be composed of a minimum of 174 healthcare workers. They will be randomly assigned to a 2-month EMI group (CUIDA-TE APP, n ≥ 58), a 2-month ecological momentary assessment (EMA) only group (MONITOR EMOCIONAL APP, n ≥ 58), or a wait-list control group (no daily monitoring nor intervention, n ≥ 58). CUIDA-TE will provide EMI if EMA reveals emotional problems, poor sleep quality/quantity, burnout, stress, or low perceived self-efficacy when regulating emotions. Depression will be the primary outcome. Secondary outcomes will include emotion regulation, quality of life, and resilience. Treatment acceptance and usability will also be measured. Primary and secondary outcomes will be obtained at pre- and post-intervention measurements, and at the 3-month follow-up for all groups.
To our knowledge, this is the first RCT that evaluates the efficacy of an APP-based EMI to improve emotion regulation skills in healthcare workers. This type of intervention might ultimately help disseminate treatments and reach a larger number of individuals than traditional face-to-face individual therapies.
ClinicalTrial.gov : NCT04958941 Registered 7 Jun 2021.
Participant recruitment has not started.
CUIDA-TE 是一款应用程序，提供以增强情绪调节为重点的跨诊断认知行为疗法。作为一种新颖的方法，它结合了生态瞬时干预（EMI），可以在出现痛苦时实时提供心理支持。该研究的主要目标是评估 CUIDA-TE 改善医护人员情绪调节的效果，该人群因 COVID-19 大流行受到了特别大的情绪影响。
在这项三臂、随机对照试验（RCT）中，研究样本将由至少 174 名医护人员组成。他们将被随机分配到为期 2 个月的 EMI 组（CUIDA-TE APP，n≥58）、为期 2 个月的生态瞬时评估（EMA）仅组（MONITOR EMOCIONAL APP，n≥58）或等待名单对照组（无日常监测或干预，n≥58）。如果 EMA 显示情绪问题、睡眠质量/数量差、倦怠、压力或情绪调节自我效能感低，CUIDA-TE 将提供 EMI。抑郁将是主要结果。次要结果将包括情绪调节、生活质量和韧性。还将测量治疗的接受度和可用性。所有组将在干预前后测量和 3 个月随访时获得主要和次要结果。
据我们所知，这是第一项评估基于应用程序的 EMI 改善医护人员情绪调节技能的 RCT。这种干预类型最终可能有助于传播治疗方法并惠及比传统面对面个体治疗更多的个体。
ClinicalTrial.gov：NCT04958941 于 2021 年 6 月 7 日注册。
尚未开始招募参与者。
